Key result
Laparoscopic adjustable gastric banding in patients with grade 3 obesity and T2DM or IFG resulted in 41% mean excess weight loss at 5 years, but maintained complete diabetes remission in only 4/22.
Why the study?
Does laparoscopic adjustable gastric banding improve metabolic outcomes and quality of life in patients with grade 3 obesity and type 2 diabetes or impaired fasting glucose?
Population
Patients with grade 3 obesity and type 2 diabetes (n=23) or impaired fasting glucose (IFG) (n=53)
Design
Cohort
Follow-up
5 years
Authors
Loading...
Sustained metabolic and QoL gains after LAGB may merit evaluation; leaves open comparative durability of T2DM remission versus other bariatric options.
Cohort (n=76)
Does laparoscopic adjustable gastric banding improve metabolic outcomes and quality of life in patients with grade 3 obesity and type 2 diabetes or impaired fasting glucose?
Laparoscopic adjustable gastric banding provides sustained improvements in metabolic parameters and quality of life at 5 years in severely obese patients, though long-term complete remission of type 2 diabetes is rare.
Caïazzo et al. (2010) conducted a cohort in Grade 3 obesity with type 2 diabetes mellitus or impaired fasting glucose (n=76). Laparoscopic adjustable gastric banding was evaluated on Metabolic outcomes and quality of life. Laparoscopic adjustable gastric banding in patients with grade 3 obesity and T2DM or IFG resulted in 41% mean excess weight loss at 5 years, but maintained complete diabetes remission in only 4/22.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: